Open Net Zero logo
Cardiopulmonary changes in humans with coronary artery disease associated with exposure to ambient concentrations of ozone.
OwnerUnited State Environmental Protection Agency - view all
Update frequencyunknown
Last updatedabout 1 year ago
Format
Overview

The dataset contains a list of cardiac and vascular biomarkers that were obtained on each day a participant visited the EPA Human Studies Facility. It also contains ozone concentrations on those days, which are publicly available on the EPA AirNow website. This dataset is not publicly accessible because: The dataset pertains to human research. It can be accessed through the following means: Requests to access data should be sent to Robert Devlin at devlin.robert@epa.gov. Format: The metadata are in the form of spreadsheets with health endpoints listed in columns and each human participant listed as a row. Similar spreadsheets contain exposure information in columns and participants in rows. This dataset is associated with the following publication: Mirowsky, J., M. Carraway, R. Dhingra, H. Tong, L. Neas, D. Diaz-Sanchez, W. Cascio, M. Case, J. Crooks, E. Hauser, E. Dowdy, W. Krause, and R. Devlin. Ozone exposure is associated with acute changes in inflammation, fibrinolysis, and endothelial cell function in coronary artery disease patients. ENVIRONMENTAL HEALTH. Academic Press Incorporated, Orlando, FL, USA, 16: 126, (2017).

air pollutioncardiovascularepidemiologyheart diseaseozone concentrations
Additional Information
KeyValue
dcat_modified2017-05-01
dcat_publisher_nameU.S. EPA Office of Research and Development (ORD)
guidhttps://doi.org/10.23719/1390160
ib1_trust_framework[]
language
Files
    Share this Dataset
    cardiopulmonary-changes-in-humans-with-coronary-artery-disease-associated-with-exposure-to-ambi
    Access and Licensing
    Access conditionsAccess control: Unknown
    License conditionsLicense: